FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2742221670> ?p ?o ?g. }

• W2742221670 endingPage "43" @default.
• W2742221670 startingPage "238" @default.
• W2742221670 abstract "Introduction: Active surveillance is a strategy to delay or prevent treatment of indolent prostate cancer. The Prostate Cancer Research International: Active Surveillance (PRIAS) criteria were developed to select patients for prostate cancer active surveillance. The objective of this study was to compare pathological findings from PRIAS-eligible and PRIAS-ineligible clinically low-risk prostate cancer patients.Methods: A D’Amico low-risk cohort of 1512 radical prostatectomy patients treated at The Ottawa Hospital or Memorial Sloan Kettering Cancer Centre between January 1995 and December 2007 was reviewed. Pathological outcomes (pT3 tumours, Gleason sum ≥7, lymph node metastases, or a composite) and clinical outcomes (prostate-specific antigen [PSA] recurrence, secondary cancer treatments, and death) were compared between PRIAS-eligible and PRIAS-ineligible cohorts.Results: The PRIAS-eligible cohort (n=945) was less likely to have Gleason score ≥7 (odds ratio [OR] 0.61; 95% confidence interval [CI] 0.49‒0.75), pT3 (OR 0.41; 95% CI 0.31‒0.55), nodal metastases (OR 0.37; 95% CI 0.10‒1.31), or any adverse feature (OR 0.56; 95% CI 0.45‒0.69) compared to the PRIAS-ineligible cohort. The probability of any adverse pathology in the PRIAS-eligible cohort was 41% vs. 56% in the PRIAS-ineligible cohort. At median followup of 3.7 years, 72 (4.8%) patients had a PSA recurrence, 24 (1.6%) received pelvic radiation, and 13 (0.9%) received androgen deprivation. No difference was detected for recurrence-free and overall survival between groups (recurrence hazard ratio [HR] 0.71; 95% CI 0.46–1.09 and survival HR 0.72; 95% CI 0.36–1.47).Conclusions: Low-risk prostate cancer patients who met PRIAS eligibility criteria are less likely to have higher-risk cancer compared to those who did not meet at least one of these criteria." @default.
• W2742221670 created "2017-08-17" @default.
• W2742221670 creator A5005699907 @default.
• W2742221670 creator A5022700654 @default.
• W2742221670 creator A5028436511 @default.
• W2742221670 creator A5030594142 @default.
• W2742221670 creator A5046934730 @default.
• W2742221670 creator A5048403085 @default.
• W2742221670 creator A5050427291 @default.
• W2742221670 creator A5058947116 @default.
• W2742221670 creator A5086280284 @default.
• W2742221670 creator A5086613220 @default.
• W2742221670 date "2017-08-11" @default.
• W2742221670 modified "2023-09-26" @default.
• W2742221670 title "An assessment of Prostate Cancer Research International: Active Surveillance (PRIAS) criteria for active surveillance of clinically low-risk prostate cancer patients" @default.
• W2742221670 cites W1484814684 @default.
• W2742221670 cites W1574577345 @default.
• W2742221670 cites W1620144640 @default.
• W2742221670 cites W1623669612 @default.
• W2742221670 cites W1853899081 @default.
• W2742221670 cites W1888139180 @default.
• W2742221670 cites W1973550636 @default.
• W2742221670 cites W1983145936 @default.
• W2742221670 cites W2003048954 @default.
• W2742221670 cites W2038289366 @default.
• W2742221670 cites W2061551581 @default.
• W2742221670 cites W2063205071 @default.
• W2742221670 cites W2064240815 @default.
• W2742221670 cites W2071128923 @default.
• W2742221670 cites W2077475521 @default.
• W2742221670 cites W2096004364 @default.
• W2742221670 cites W2101482344 @default.
• W2742221670 cites W2102229192 @default.
• W2742221670 cites W2102558162 @default.
• W2742221670 cites W2102706911 @default.
• W2742221670 cites W2108330864 @default.
• W2742221670 cites W2110881680 @default.
• W2742221670 cites W2114709771 @default.
• W2742221670 cites W2130502504 @default.
• W2742221670 cites W2141101208 @default.
• W2742221670 cites W2141903944 @default.
• W2742221670 cites W2145274312 @default.
• W2742221670 cites W2149339272 @default.
• W2742221670 cites W2153323010 @default.
• W2742221670 cites W2156549595 @default.
• W2742221670 cites W2157996158 @default.
• W2742221670 cites W2162661850 @default.
• W2742221670 doi "https://doi.org/10.5489/cuaj.4093" @default.
• W2742221670 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5542829" @default.
• W2742221670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28798822" @default.
• W2742221670 hasPublicationYear "2017" @default.
• W2742221670 type Work @default.
• W2742221670 sameAs 2742221670 @default.
• W2742221670 citedByCount "6" @default.
• W2742221670 countsByYear W27422216702019 @default.
• W2742221670 countsByYear W27422216702021 @default.
• W2742221670 countsByYear W27422216702022 @default.
• W2742221670 countsByYear W27422216702023 @default.
• W2742221670 crossrefType "journal-article" @default.
• W2742221670 hasAuthorship W2742221670A5005699907 @default.
• W2742221670 hasAuthorship W2742221670A5022700654 @default.
• W2742221670 hasAuthorship W2742221670A5028436511 @default.
• W2742221670 hasAuthorship W2742221670A5030594142 @default.
• W2742221670 hasAuthorship W2742221670A5046934730 @default.
• W2742221670 hasAuthorship W2742221670A5048403085 @default.
• W2742221670 hasAuthorship W2742221670A5050427291 @default.
• W2742221670 hasAuthorship W2742221670A5058947116 @default.
• W2742221670 hasAuthorship W2742221670A5086280284 @default.
• W2742221670 hasAuthorship W2742221670A5086613220 @default.
• W2742221670 hasBestOaLocation W27422216701 @default.
• W2742221670 hasConcept C121608353 @default.
• W2742221670 hasConcept C126322002 @default.
• W2742221670 hasConcept C143998085 @default.
• W2742221670 hasConcept C207103383 @default.
• W2742221670 hasConcept C207886595 @default.
• W2742221670 hasConcept C2776141087 @default.
• W2742221670 hasConcept C2779466945 @default.
• W2742221670 hasConcept C2780192828 @default.
• W2742221670 hasConcept C29456083 @default.
• W2742221670 hasConcept C44249647 @default.
• W2742221670 hasConcept C71924100 @default.
• W2742221670 hasConcept C72563966 @default.
• W2742221670 hasConceptScore W2742221670C121608353 @default.
• W2742221670 hasConceptScore W2742221670C126322002 @default.
• W2742221670 hasConceptScore W2742221670C143998085 @default.
• W2742221670 hasConceptScore W2742221670C207103383 @default.
• W2742221670 hasConceptScore W2742221670C207886595 @default.
• W2742221670 hasConceptScore W2742221670C2776141087 @default.
• W2742221670 hasConceptScore W2742221670C2779466945 @default.
• W2742221670 hasConceptScore W2742221670C2780192828 @default.
• W2742221670 hasConceptScore W2742221670C29456083 @default.
• W2742221670 hasConceptScore W2742221670C44249647 @default.
• W2742221670 hasConceptScore W2742221670C71924100 @default.
• W2742221670 hasConceptScore W2742221670C72563966 @default.
• W2742221670 hasIssue "8" @default.
• W2742221670 hasLocation W27422216701 @default.
• W2742221670 hasLocation W27422216702 @default.
• W2742221670 hasLocation W27422216703 @default.

• next